APO Research
Talk to an analyst

APO RESEARCH · REPORT

Computational Biology Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Computational Biology Platform Market Outlook and Growth Opportunities 2026

1 January 2026204 pages

Choose your research edition.

Industry ResearchComputational Biology Platform Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Computational Biology Platform Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Computational Biology Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Computational Biology Platform Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Computational Biology Platform Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Computational Biology Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Computational Biology Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Computational Biology Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Computational Biology Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Computational Biology Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Computational Biology Platform market include Saturn Cloud, Terra, Lamin, DNAnexus, Seven Bridges, Illumina, LatchBio, Lifebit and Dockstore, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Computational Biology Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Computational Biology Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Computational Biology Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Computational Biology Platform market.

Computational Biology Platform Segment by Company

Saturn Cloud

Terra

Lamin

DNAnexus

Seven Bridges

Illumina

LatchBio

Lifebit

Dockstore

BC Platforms

Deep Origin

Biodonostia HRI

PLOS

CD ComputaBio

Cellworks

Basque Digital Innovation HUB (BDIH)

Pluto Bioinformatics

Computational Biology Platform Segment by Type

Cloud Based

On-Premises

Computational Biology Platform Segment by Application

Large Enterprises

SMEs

Computational Biology Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Computational Biology Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Computational Biology Platform key companies, revenue, market share, and recent developments.

3. To split the Computational Biology Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Computational Biology Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Computational Biology Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Computational Biology Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computational Biology Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Computational Biology Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computational Biology Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Computational Biology Platform industry.

Chapter 3: Detailed analysis of Computational Biology Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Computational Biology Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Computational Biology Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Computational Biology Platform Industry Trends Table 2. Computational Biology Platform Industry Drivers Table 3. Computational Biology Platform Industry Opportunities and Challenges Table 4. Computational Biology Platform Industry Restraints Table 5. Global Computational Biology Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Computational Biology Platform Revenue Share by Company (2021-2026) Table 7. Global Computational Biology Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Computational Biology Platform Key Company Manufacturing Base & Headquarters Table 9. Global Computational Biology Platform Company, Product Type & Application Table 10. Global Computational Biology Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Computational Biology Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud Based Table 15. Significant Companies of On-Premises Table 16. Global Computational Biology Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Computational Biology Platform Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Computational Biology Platform Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Computational Biology Platform Sales Value Share by Type (2021-2026) Table 20. Global Computational Biology Platform Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Large Enterprises Table 22. Significant Companies of SMEs Table 23. Global Computational Biology Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Computational Biology Platform Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Computational Biology Platform Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Computational Biology Platform Sales Value Share by Application (2021-2026) Table 27. Global Computational Biology Platform Sales Value Share by Application (2027-2032) Table 28. Global Computational Biology Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Computational Biology Platform Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Computational Biology Platform Sales Value Share by Region (2021-2026) Table 31. Global Computational Biology Platform Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Computational Biology Platform Sales Value Share by Region (2027-2032) Table 33. Global Computational Biology Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Computational Biology Platform Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Computational Biology Platform Sales Value Market Share by Country (2021-2026) Table 36. Global Computational Biology Platform Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Computational Biology Platform Sales Value Market Share by Country (2027-2032) Table 38. Saturn Cloud Company Information Table 39. Saturn Cloud Business Overview Table 40. Saturn Cloud Computational Biology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Saturn Cloud Computational Biology Platform Product Portfolio Table 42. Saturn Cloud Recent Development Table 43. Terra Company Information Table 44. Terra Business Overview Table 45. Terra Computational Biology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Terra Computational Biology Platform Product Portfolio Table 47. Terra Recent Development Table 48. Lamin Company Information Table 49. Lamin Business Overview Table 50. Lamin Computational Biology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Lamin Computational Biology Platform Product Portfolio Table 52. Lamin Recent Development Table 53. DNAnexus Company Information Table 54. DNAnexus Business Overview Table 55. DNAnexus Computational Biology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. DNAnexus Computational Biology Platform Product Portfolio Table 57. DNAnexus Recent Development Table 58. Seven Bridges Company Information Table 59. Seven Bridges Business Overview Table 60. Seven Bridges Computational Biology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Seven Bridges Computational Biology Platform Product Portfolio Table 62. Seven Bridges Recent Development Table 63. Illumina Company Information Table 64. Illumina Business Overview Table 65. Illumina Computational Biology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Illumina Computational Biology Platform Product Portfolio Table 67. Illumina Recent Development Table 68. LatchBio Company Information Table 69. LatchBio Business Overview Table 70. LatchBio Computational Biology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. LatchBio Computational Biology Platform Product Portfolio Table 72. LatchBio Recent Development Table 73. Lifebit Company Information Table 74. Lifebit Business Overview Table 75. Lifebit Computational Biology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Lifebit Computational Biology Platform Product Portfolio Table 77. Lifebit Recent Development Table 78. Dockstore Company Information Table 79. Dockstore Business Overview Table 80. Dockstore Computational Biology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Dockstore Computational Biology Platform Product Portfolio Table 82. Dockstore Recent Development Table 83. BC Platforms Company Information Table 84. BC Platforms Business Overview Table 85. BC Platforms Computational Biology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. BC Platforms Computational Biology Platform Product Portfolio Table 87. BC Platforms Recent Development Table 88. Deep Origin Company Information Table 89. Deep Origin Business Overview Table 90. Deep Origin Computational Biology Platform Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Deep Origin Computational Biology Platform Product Portfolio Table 92. Deep Origin Recent Development Table 93. Biodonostia HRI Company Information Table 94. Biodonostia HRI Business Overview Table 95. Biodonostia HRI Computational Biology Platform Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Biodonostia HRI Computational Biology Platform Product Portfolio Table 97. Biodonostia HRI Recent Development Table 98. PLOS Company Information Table 99. PLOS Business Overview Table 100. PLOS Computational Biology Platform Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. PLOS Computational Biology Platform Product Portfolio Table 102. PLOS Recent Development Table 103. CD ComputaBio Company Information Table 104. CD ComputaBio Business Overview Table 105. CD ComputaBio Computational Biology Platform Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. CD ComputaBio Computational Biology Platform Product Portfolio Table 107. CD ComputaBio Recent Development Table 108. Cellworks Company Information Table 109. Cellworks Business Overview Table 110. Cellworks Computational Biology Platform Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Cellworks Computational Biology Platform Product Portfolio Table 112. Cellworks Recent Development Table 113. Basque Digital Innovation HUB (BDIH) Company Information Table 114. Basque Digital Innovation HUB (BDIH) Business Overview Table 115. Basque Digital Innovation HUB (BDIH) Computational Biology Platform Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Basque Digital Innovation HUB (BDIH) Computational Biology Platform Product Portfolio Table 117. Basque Digital Innovation HUB (BDIH) Recent Development Table 118. Pluto Bioinformatics Company Information Table 119. Pluto Bioinformatics Business Overview Table 120. Pluto Bioinformatics Computational Biology Platform Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Pluto Bioinformatics Computational Biology Platform Product Portfolio Table 122. Pluto Bioinformatics Recent Development Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Computational Biology Platform Product Image Figure 2. Global Computational Biology Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Computational Biology Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Computational Biology Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud Based Image Figure 8. On-Premises Image Figure 9. Global Computational Biology Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Computational Biology Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Computational Biology Platform Sales Value Share by Type (2021-2032) Figure 12. Large Enterprises Image Figure 13. SMEs Image Figure 14. Global Computational Biology Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Computational Biology Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Computational Biology Platform Sales Value Share by Application (2021-2032) Figure 17. Global Computational Biology Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Computational Biology Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Computational Biology Platform Sales Value (2021-2032) & (US$ Million) Figure 20. North America Computational Biology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Computational Biology Platform Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Computational Biology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Computational Biology Platform Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Computational Biology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Computational Biology Platform Sales Value (2021-2032) & (US$ Million) Figure 26. South America Computational Biology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Computational Biology Platform Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Computational Biology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Computational Biology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Computational Biology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Computational Biology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud Based
  • On-Premises
Applications
  • Large Enterprises
  • SMEs
Companies covered
  • Saturn Cloud
  • Terra
  • Lamin
  • DNAnexus
  • Seven Bridges
  • Illumina
  • LatchBio
  • Lifebit
  • Dockstore
  • BC Platforms
  • Deep Origin
  • Biodonostia HRI
  • PLOS
  • CD ComputaBio
  • Cellworks
  • Basque Digital Innovation HUB (BDIH)
  • Pluto Bioinformatics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Computational Biology Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Computational Biology Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Computational Biology Platform Market Dynamics
  1. 2.1 Computational Biology Platform Industry Trends
  2. 2.2 Computational Biology Platform Industry Drivers
  3. 2.3 Computational Biology Platform Industry Opportunities and Challenges
  4. 2.4 Computational Biology Platform Industry Restraints
3 Computational Biology Platform Market by Company
  1. 3.1 Global Computational Biology Platform Company Revenue Ranking in 2025
  2. 3.2 Global Computational Biology Platform Revenue by Company (2021-2026)
  3. 3.3 Global Computational Biology Platform Company Ranking (2024-2026)
  4. 3.4 Global Computational Biology Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Computational Biology Platform Company Product Type and Application
  6. 3.6 Global Computational Biology Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Computational Biology Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Computational Biology Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Computational Biology Platform Market by Type
  1. 4.1 Computational Biology Platform Type Introduction
  2. 4.1.1 Cloud Based
  3. 4.1.2 On-Premises
  4. 4.2 Global Computational Biology Platform Sales Value by Type
  5. 4.2.1 Global Computational Biology Platform Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Computational Biology Platform Sales Value by Type (2021-2032)
  7. 4.2.3 Global Computational Biology Platform Sales Value Share by Type (2021-2032)
5 Computational Biology Platform Market by Application
  1. 5.1 Computational Biology Platform Application Introduction
  2. 5.1.1 Large Enterprises
  3. 5.1.2 SMEs
  4. 5.2 Global Computational Biology Platform Sales Value by Application
  5. 5.2.1 Global Computational Biology Platform Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Computational Biology Platform Sales Value by Application (2021-2032)
  7. 5.2.3 Global Computational Biology Platform Sales Value Share by Application (2021-2032)
6 Computational Biology Platform Regional Value Analysis
  1. 6.1 Global Computational Biology Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Computational Biology Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Computational Biology Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Computational Biology Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Computational Biology Platform Sales Value (2021-2032)
  7. 6.3.2 North America Computational Biology Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Computational Biology Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Computational Biology Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Computational Biology Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Computational Biology Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Computational Biology Platform Sales Value (2021-2032)
  16. 6.6.2 South America Computational Biology Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Computational Biology Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Computational Biology Platform Sales Value Share by Country, 2025 VS 2032
7 Computational Biology Platform Country-level Value Analysis
  1. 7.1 Global Computational Biology Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Computational Biology Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Computational Biology Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Computational Biology Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Computational Biology Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Computational Biology Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Computational Biology Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Computational Biology Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Computational Biology Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Computational Biology Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Computational Biology Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Computational Biology Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Computational Biology Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Computational Biology Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Computational Biology Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Computational Biology Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Computational Biology Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Computational Biology Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Computational Biology Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Computational Biology Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Computational Biology Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Computational Biology Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Computational Biology Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Computational Biology Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Computational Biology Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Computational Biology Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Computational Biology Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Computational Biology Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Computational Biology Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Computational Biology Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Computational Biology Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Computational Biology Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Computational Biology Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Computational Biology Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Saturn Cloud
  2. 8.1.1 Saturn Cloud Company Information
  3. 8.1.2 Saturn Cloud Business Overview
  4. 8.1.3 Saturn Cloud Computational Biology Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Saturn Cloud Computational Biology Platform Product Portfolio
  6. 8.1.5 Saturn Cloud Recent Developments
  7. 8.2 Terra
  8. 8.2.1 Terra Company Information
  9. 8.2.2 Terra Business Overview
  10. 8.2.3 Terra Computational Biology Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Terra Computational Biology Platform Product Portfolio
  12. 8.2.5 Terra Recent Developments
  13. 8.3 Lamin
  14. 8.3.1 Lamin Company Information
  15. 8.3.2 Lamin Business Overview
  16. 8.3.3 Lamin Computational Biology Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Lamin Computational Biology Platform Product Portfolio
  18. 8.3.5 Lamin Recent Developments
  19. 8.4 DNAnexus
  20. 8.4.1 DNAnexus Company Information
  21. 8.4.2 DNAnexus Business Overview
  22. 8.4.3 DNAnexus Computational Biology Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DNAnexus Computational Biology Platform Product Portfolio
  24. 8.4.5 DNAnexus Recent Developments
  25. 8.5 Seven Bridges
  26. 8.5.1 Seven Bridges Company Information
  27. 8.5.2 Seven Bridges Business Overview
  28. 8.5.3 Seven Bridges Computational Biology Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Seven Bridges Computational Biology Platform Product Portfolio
  30. 8.5.5 Seven Bridges Recent Developments
  31. 8.6 Illumina
  32. 8.6.1 Illumina Company Information
  33. 8.6.2 Illumina Business Overview
  34. 8.6.3 Illumina Computational Biology Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Illumina Computational Biology Platform Product Portfolio
  36. 8.6.5 Illumina Recent Developments
  37. 8.7 LatchBio
  38. 8.7.1 LatchBio Company Information
  39. 8.7.2 LatchBio Business Overview
  40. 8.7.3 LatchBio Computational Biology Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LatchBio Computational Biology Platform Product Portfolio
  42. 8.7.5 LatchBio Recent Developments
  43. 8.8 Lifebit
  44. 8.8.1 Lifebit Company Information
  45. 8.8.2 Lifebit Business Overview
  46. 8.8.3 Lifebit Computational Biology Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lifebit Computational Biology Platform Product Portfolio
  48. 8.8.5 Lifebit Recent Developments
  49. 8.9 Dockstore
  50. 8.9.1 Dockstore Company Information
  51. 8.9.2 Dockstore Business Overview
  52. 8.9.3 Dockstore Computational Biology Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dockstore Computational Biology Platform Product Portfolio
  54. 8.9.5 Dockstore Recent Developments
  55. 8.10 BC Platforms
  56. 8.10.1 BC Platforms Company Information
  57. 8.10.2 BC Platforms Business Overview
  58. 8.10.3 BC Platforms Computational Biology Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 BC Platforms Computational Biology Platform Product Portfolio
  60. 8.10.5 BC Platforms Recent Developments
  61. 8.11 Deep Origin
  62. 8.11.1 Deep Origin Company Information
  63. 8.11.2 Deep Origin Business Overview
  64. 8.11.3 Deep Origin Computational Biology Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Deep Origin Computational Biology Platform Product Portfolio
  66. 8.11.5 Deep Origin Recent Developments
  67. 8.12 Biodonostia HRI
  68. 8.12.1 Biodonostia HRI Company Information
  69. 8.12.2 Biodonostia HRI Business Overview
  70. 8.12.3 Biodonostia HRI Computational Biology Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Biodonostia HRI Computational Biology Platform Product Portfolio
  72. 8.12.5 Biodonostia HRI Recent Developments
  73. 8.13 PLOS
  74. 8.13.1 PLOS Company Information
  75. 8.13.2 PLOS Business Overview
  76. 8.13.3 PLOS Computational Biology Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 PLOS Computational Biology Platform Product Portfolio
  78. 8.13.5 PLOS Recent Developments
  79. 8.14 CD ComputaBio
  80. 8.14.1 CD ComputaBio Company Information
  81. 8.14.2 CD ComputaBio Business Overview
  82. 8.14.3 CD ComputaBio Computational Biology Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CD ComputaBio Computational Biology Platform Product Portfolio
  84. 8.14.5 CD ComputaBio Recent Developments
  85. 8.15 Cellworks
  86. 8.15.1 Cellworks Company Information
  87. 8.15.2 Cellworks Business Overview
  88. 8.15.3 Cellworks Computational Biology Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cellworks Computational Biology Platform Product Portfolio
  90. 8.15.5 Cellworks Recent Developments
  91. 8.16 Basque Digital Innovation HUB (BDIH)
  92. 8.16.1 Basque Digital Innovation HUB (BDIH) Company Information
  93. 8.16.2 Basque Digital Innovation HUB (BDIH) Business Overview
  94. 8.16.3 Basque Digital Innovation HUB (BDIH) Computational Biology Platform Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Basque Digital Innovation HUB (BDIH) Computational Biology Platform Product Portfolio
  96. 8.16.5 Basque Digital Innovation HUB (BDIH) Recent Developments
  97. 8.17 Pluto Bioinformatics
  98. 8.17.1 Pluto Bioinformatics Company Information
  99. 8.17.2 Pluto Bioinformatics Business Overview
  100. 8.17.3 Pluto Bioinformatics Computational Biology Platform Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Pluto Bioinformatics Computational Biology Platform Product Portfolio
  102. 8.17.5 Pluto Bioinformatics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst